Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly.

The Journal of clinical endocrinology and metabolism - 1 Aug 2005

Filopanti M, Ronchi C, Ballarè E, Bondioni S, Lania A G, Losa M, Gelmini S, Peri A, Orlando C, Beck-Peccoz P, Spada A

Abstract excerpt

OBJECTIVE: The aim of the study was to investigate the possible correlation of single nucleotide polymorphisms in somatostatin receptor (SSTR)2 and SSTR5 genes with the responsiveness to somatostatin analogs in a cohort of acromegalic patients. STUDY DESIGN: Three single nucleotide polymorphisms (a-83 g, c-57 g, and t80c) of SSTR2 and three (t-461c, c325t, and c1004t) of SSTR5 were analyzed in 66 acromegalic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 5' Untranslated Regions
Share to Acromegaly

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Drug Resistance

Share to Polymorphism, Single Nucleotide

Share to Receptors, Somatostatin

Share to RNA, Messenger

Share to Somatostatin

Source

Identifiers

PMID: 15914528
DOI: 10.1210/jc.2005-0132

Genes

SSTR5
SSTR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly.PMID 15914528Read ↗

Identification of somatostatin receptor type 5 gene polymorphisms associated with acromegaly.Semantic proximity Read ↗

Genetic abnormalities of somatostatin receptors in pituitary tumors.Semantic proximity Read ↗

Genetic Predictors of Response to Different Medical Therapies in Acromegaly.Semantic proximity Read ↗

Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment.Semantic proximity Read ↗

Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter study.Semantic proximity Read ↗

Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.Semantic proximity Read ↗

SOCS2 polymorphisms are not associated with clinical and biochemical phenotypes in acromegalic patients.Semantic proximity Read ↗

gsp Mutation Is Not a Molecular Biomarker of Long-Term Response to First-Generation Somatostatin Receptor Ligands in AcromegalySemantic proximity Read ↗

Human Somatostatin Receptor Subtypes in Acromegaly: Distinct Patterns of Messenger Ribonucleic Acid Expression and Hormone Suppression Identify Different Tumoral PhenotypesSemantic proximity Read ↗

GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegalySemantic proximity Read ↗

Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3Semantic proximity Read ↗

The Potential Roles of 77C>T Variant and Growth Hormone-Releasing Hormone Elevation in Pituitary Adenoma Cases Associated with AcromegalySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.